Gilead Sciences, Inc.
Public
GILD
SectorHealthcare
CountryUnited States
Market cap164.59B
Gilead Sciences, Inc.,"A research-based biopharmaceutical company and global leader in HIV/AIDS therapy, with a significant presence in oncology and viral hepatitis treatments."
